Intravitreal ranibizumab as a primary or a combined treatment for severe retinopathy of prematurity

PURPOSE: The aim of the study was to assess the outcomes of severe retinopathy of prematurity (ROP) in zone I or posterior zone II treated with intravitreal ranibizumab (IVR) as monotherapy or combined treatment with laser photocoagulation. METHODS: This is a retrospective study analyzing clinical r...

Descripción completa

Detalles Bibliográficos
Autores principales: Arámbulo, Odalis, Dib, Gabriel, Iturralde, Juan, Duran, Fahir, Brito, Miguel, Fortes Filho, João B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631423/
https://www.ncbi.nlm.nih.gov/pubmed/26604673
http://dx.doi.org/10.2147/OPTH.S90979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631423/
https://www.ncbi.nlm.nih.gov/pubmed/26604673
http://dx.doi.org/10.2147/OPTH.S90979

Ejemplares similares